Viewing Study NCT01069120


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-01-06 @ 4:10 AM
Study NCT ID: NCT01069120
Status: TERMINATED
Last Update Posted: 2014-08-21
First Post: 2010-02-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids
Sponsor: Repros Therapeutics Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-04
Start Date Type: None
Primary Completion Date: 2009-08
Primary Completion Date Type: ACTUAL
Completion Date: 2009-08
Completion Date Type: ACTUAL
First Submit Date: 2010-02-10
First Submit QC Date: None
Study First Post Date: 2010-02-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-06-25
Results First Submit QC Date: None
Results First Post Date: 2014-08-21
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-08-05
Last Update Post Date: 2014-08-21
Last Update Post Date Type: ESTIMATED